SiRNA (small-interfering RNA) is a gene-silencing RNA technology that is capable of directly targeting the coronavirus’ genome to stop the pathogen from replicating. This experimental direct-acting antiviral therapy is capable of reducing the viral load by 99.9 per cent, making it a potential treatment against the COVID-19 infection. There is a possibility of this treatment being successful against all betacoronaviruses like that of the original SARS-CoV-2 and its new variants.


Leave a Reply